Characteristic | Number of patients (%) |
---|---|
Sex | |
Male | 26 (78.79) |
Female | 7 (21.21) |
Age (years) | |
Mean ± SD | 48.64 ± 10.29 |
 ≥ 50 | 14 (42.42) |
 < 50 | 19 (57.58) |
Tumor category | |
T1 | 5 (15.15) |
T2 | 6 (18.18) |
T3 | 11 (33.33) |
T4 | 11 (33.33) |
Node category | |
N0 | 2 (6.06) |
N1 | 13 (39.39) |
N2 | 14 (42.42) |
N3 | 4 (12.12) |
Clinical stage | |
II | 3 (9.09) |
III | 15 (45.45) |
IVa | 15 (45.45) |
SUVmax in primary tumor | |
Mean ± SD | 11.43 ± 5.17 |
SUVmax in recurrent tumor | |
Mean ± SD | 7.73 ± 4.06 |
Vpri in primary tumor (SUV = 2.5) | |
Median (range) | 22.85 (4.16–105.09) cm3 |
Vhigh in primary tumor (SUV50%max) | |
Median (range) | 5.57 (0–43.07) cm3 |
Vrecur in recurrent tumor (SUV = 2.5) | |
Median (range) | 9.98 (0.32–59.46) cm3 |